Fisher & Paykel Healthcare (FPH.AX)
Trading: SELL @ $12.05
Signal Strength: MEDIUM
Fisher & Paykel Healthcare (ASX:FPH) currently has negative Volume MACD of -6531. This means the signal line is less than the Volume MACD line signalling a bearish movement.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement
Volume Moving Average Convergence/Divergence (VMACD) is an indicator that shows the relationship between two moving averages. It is calculated as a difference between the fast and slow moving averages. The historically popular is the difference between a securities 26-day and 12-day Exponential Moving Averages (EMA).
Calculation: Moving Average Convergence Divergence Volume (VMACD):
1) VMACD Line: (12-day EMA - 26-day EMA);
2) Signal Line: 9-day EMA of VMACD Line;
3) VMACD Histogram: VMACD Line - Signal Line;
PROFILE: Fisher & Paykel Healthcare (FPH.AX)
Stock Exchange: ASX
Company: Fisher & Paykel Healthcare
Ticker Codes: | FPH.AX | ASX:FPH |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA). It operates through four segments: New Zealand, North America, Europe, and Asia-Pacific. The company offers adult respiratory products, such as AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, including resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers surgical humidification systems; and homecare products comprising masks, CPAP devices, data management, humidifiers, and accessories. It markets and sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
|MVF Monash IVF||0.96||3.8||260,591||-24,949||BEARISH|
|REA REA Group||74.75||3.5||228,972||-35,172||BEARISH|
|SPO Spotless Holdings||1.74||2.4||47,148||-13,721||BEARISH|